Notice of Investigation – Multiple Conditions – Instruments Sunsetting on 1 October 2026

Overview

The Repatriation Medical Authority (RMA) has published a notice of investigation regarding multiple conditions under Section 196G of the Veterans' Entitlements Act 1986 (VEA), with instruments sunsetting on 1 October 2026. This initiative aims to review the contents of Statements of Principles concerning various medical conditions to determine whether they are war-caused, defence-caused, a service injury, a service disease, or a service death. The listed conditions include antiphospholipid syndrome, Barrett's oesophagus, benign neoplasm of the eye and adnexa, and others, each with specific instrument numbers and commencement dates. The RMA invites submissions from eligible individuals, organisations representing veterans, and experts in relevant fields, with a deadline of 26 July 2024. The first meeting for these investigations is scheduled for 6 August 2024, and submissions can be made electronically, by email, or by post, as detailed in the RMA website and submission guidelines.

Scope and Application

The Veterans' Entitlements Act 1986, as referenced in the Gazette C2024G00379, mandates the Repatriation Medical Authority (the Authority) to conduct investigations into specific medical conditions related to veterans' health. These investigations are intended to review the contents of Statements of Principles for certain conditions including antiphospholipid syndrome, Barrett's oesophagus, and others listed, which commenced on various dates in 2016. The Authority seeks submissions from individuals and organisations eligible to make claims for pension or compensation under the Act, representatives of veterans and their dependants, and experts in relevant fields. This call for submissions extends to entities such as the Repatriation Commission and the Military Rehabilitation and Compensation Commission. The Act applies nationally within Australia, and the Authority is tasked with determining the war-related or service-related nature of these conditions and their potential to be caused by or during service. Submissions can be made electronically through the RMA website, by email, or by post, with the deadline set for 26 July 2024. The Authority's investigations and findings may influence the eligibility criteria and benefits for veterans under the Act.

Key Provisions

The notice issued by the Repatriation Medical Authority (the Authority) under section 196G of the Veterans' Entitlements Act 1986 (the VEA) outlines its intention to investigate the contents of Statements of Principles concerning specific medical conditions (section 196B(7) of the VEA). The conditions under review include Antiphospholipid syndrome, Barrett's oesophagus, Benign neoplasm of the eye and adnexa, Cholelithiasis, Clonorchiasis, Cut, stab, abrasion and laceration, Ganglion, Incisional hernia, Malignant neoplasm of the urethra, Opisthorchiasis, Optochiasmatic arachnoiditis, Otosclerosis, Parkinson's disease and secondary parkinsonism, Sarcoidosis, Scheuermann's disease, Spasmodic torticollis, Suicide and attempted suicide, each identified by their respective Instrument Numbers and commencement dates. The Authority seeks to determine whether new information exists regarding how these conditions may be suffered or contracted, or how death from these conditions may occur, and the extent to which these conditions or deaths may be attributable to war, defence, service injury, disease, or death. The obligations imposed by the Act on the Authority and relevant stakeholders include the requirement to review and evaluate new information about the listed medical conditions to ascertain their war-related or service-related origins. The Authority must consider submissions from eligible claimants, organisations representing veterans and related groups, and experts in relevant fields, as outlined in the notice. Submissions must be made in writing and submitted to the Authority by 26 July 2024. This process ensures that the Authority has access to a broad spectrum of information and perspectives, facilitating a thorough and comprehensive review of the conditions in question. The notice also clarifies the consequences of non-compliance with the statutory requirements. While the notice does not explicitly state penalties for non-compliance, it is implied that failure to submit required information or to adhere to the statutory timelines could result in legal repercussions. These could include civil or administrative penalties for individuals or organisations that do not meet their obligations under the VEA. Additionally, if the Authority fails to properly review the submissions and make findings, it could face scrutiny or legal challenges regarding its adherence to the legislative mandate. The Authority, in its role, must ensure that all submissions are reviewed in a timely and thorough manner to comply with the statutory requirements. This involves setting up and conducting investigations as per the notice, which includes the scheduled meeting on 6 August 2024. The Authority is also tasked with publishing findings and ensuring that the process is transparent and inclusive, allowing all relevant parties to contribute to the review of the Statements of Principles. This structured approach helps maintain the integrity and effectiveness of the review process, ensuring that the findings are robust and well-supported by the evidence and submissions received.